Yen Ly Tran
About Yen Ly Tran
Yen Ly Tran serves as the Director of Drug Safety and Pharmacovigilance Operations at Neurelis, Inc., a position she has held since 2022. With over two decades of experience in nursing and pharmacovigilance, she has previously worked in various roles at Allergan, AbbVie, and Watson Pharmaceuticals.
Current Role at Neurelis
Yen Ly Tran serves as the Director of Drug Safety and Pharmacovigilance Operations at Neurelis, Inc. since 2022. In this role, she oversees drug safety protocols and ensures compliance with pharmacovigilance regulations. Her work is conducted remotely, allowing her to manage operations effectively while collaborating with various teams.
Professional Background
Yen Ly Tran has extensive experience in the pharmaceutical and healthcare sectors. She began her career as a Registered Nurse at St. Joseph Health System, where she worked for 11 years. She transitioned into drug safety roles at Watson Pharmaceuticals and Allergan, holding various positions including Drug Safety Manager and Director of Pharmacovigilance Systems. She also worked at AbbVie as Director of PV Systems before joining Neurelis.
Education and Qualifications
Yen Ly Tran earned her Bachelor of Science in Nursing (BSN) from Azusa Pacific University, completing her studies from 1998 to 2001. This educational background provided her with foundational knowledge in nursing, which she later applied in her roles within drug safety and pharmacovigilance.
Previous Positions in Pharmacovigilance
Throughout her career, Yen Ly Tran has held multiple positions in pharmacovigilance. At Allergan, she progressed from Senior Pharmacovigilance Specialist to Director of PV Systems. Her tenure at Watson Pharmaceuticals included roles as Drug Safety Specialist and Drug Safety Manager. These positions allowed her to develop expertise in case processing and safety reporting.
Experience in Healthcare
Before her focus on drug safety, Yen Ly Tran worked as a Registered Nurse for over a decade. This experience in direct patient care has contributed to her understanding of pharmacovigilance and the importance of patient safety in the pharmaceutical industry.